Evidence map›Paper›PMID 36678452›Full record

ArticlePathogens (Basel, Switzerland)2023

Role of a 49 kDa

Bertha Espinoza, Ignacio Martínez, María Luisa Martínez-Velasco, Miriam Rodríguez-Sosa, Augusto González-Canto, Alicia Vázquez-Mendoza, Luis I Terrazas

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Stage-InformedMicroorganisms · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Pathogens (Basel, Switzerland) · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bertha EspinozaDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México C.P. 04510, Mexico.
Ignacio MartínezDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México C.P. 04510, Mexico.ORCID 0000-0003-1108-3641
María Luisa Martínez-VelascoDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México C.P. 04510, Mexico.
Miriam Rodríguez-SosaUnidad de Investigación en Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla C.P. 54090, Mexico.ORCID 0000-0003-2911-9390
Augusto González-CantoDepartamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México C.P. 04510, Mexico.
Alicia Vázquez-MendozaUnidad de Investigación en Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla C.P. 54090, Mexico.
Luis I TerrazasUnidad de Investigación en Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla C.P. 54090, Mexico.ORCID 0000-0003-4649-4117
Universidad Nacional Autónoma de México · MXAutonomous University of Tlaxcala · MX

Funding

Instituto de Ciencia y Tecnología DF PICSA: 10-130National Autonomous University of Mexico PAPIIT:IN206620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

infection processMASP familymMGLTrypanosoma cruzi

Identifiers

PMID36678452
PMCPMC9865002
OpenAlexW4313824849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.